Patents by Inventor DongLi Chen

DongLi Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9930651
    Abstract: Disclosed are a downlink control information configuration and acquisition method, a base station and a terminal, wherein the base station configures a plurality of sets of receiving information for the terminal via a terminal specific high-layer signaling, and the base station indicates, to the terminal, which set in the plurality of sets of receiving information to use to perform a DMRS and/or physical downlink shared channel (PDSCH) reception by using at least one of the following information: a localized virtual resource block/distributed virtual resource block assignment (LVRB/DVRB) bit in the DCI Format 1A; a control channel mode where the DCI Format 1A is located, PDCCH and ePDCCH; an ePDCCH transmission mode where the DCI Format 1A is located, diversity transmission mode and localized transmission mode; and an ePDCCH cluster where the DCI Format 1A is located.
    Type: Grant
    Filed: August 26, 2013
    Date of Patent: March 27, 2018
    Assignee: ZTE CORPORATION
    Inventors: Senbao Guo, Yunfeng Sun, Junfeng Zhang, Dongli Chen
  • Patent number: 9872311
    Abstract: A method for notifying a downlink demodulation pilot control signaling, includes: a base station side notifying a user equipment (UE) side of an index of a virtual signaling group and/or index of port offset signaling group used when generating a downlink pilot sequence and/or mapping the generated downlink pilot sequence through at least one of the following information: UE-specific or common high layer signaling; antenna indication information of DL_Grant; new data indication information in a Disable TB signaling in the DL_Grant; scrambling indication information in the DL_Grant; in a UE-specific or common search space, an aggregation level of the DL_Grant, a relative position of a first control channel element of the DL_Grant in the UE-specific or common search space, a subframe number where the DL_Grant is located and a system frame number where the DL_Grant is located.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: January 16, 2018
    Assignee: ZTE Corporation
    Inventors: Senbao Guo, Yunfeng Sun, Junfeng Zhang, Dongli Chen, Wenfeng Zhang
  • Publication number: 20150341958
    Abstract: A method for notifying a downlink demodulation pilot control signaling, includes: a base station side notifying a user equipment (UE) side of an index of a virtual signaling group and/or index of port offset signaling group used when generating a downlink pilot sequence and/or mapping the generated downlink pilot sequence through at least one of the following information: UE-specific or common high layer signaling; antenna indication information of DL_Grant; new data indication information in a Disable TB signaling in the DL_Grant; scrambling indication information in the DL_Grant; in a UE-specific or common search space, an aggregation level of the DL_Grant, a relative position of a first control channel element of the DL_Grant in the UE-specific or common search space, a subframe number where the DL_Grant is located and a system frame number where the DL_Grant is located.
    Type: Application
    Filed: December 21, 2012
    Publication date: November 26, 2015
    Inventors: Senbao GUO, Yunfeng SUN, Junfeng ZHANG, Dongli CHEN, Wenfeng ZHANG
  • Publication number: 20150334683
    Abstract: A downlink control information configuration and acquisition method, base station and terminal. The base station configures a plurality of sets of received information for the terminal via dedicated high-layer signalling of the terminal, and the base station indicates which set of the plurality of sets of received information is to be used by the terminal to receive a DMRS and/or physical downlink shared channel (PDSCH) using at least one of the following pieces of information: LVRB/DVRB bits allocated by a centralized/distributed virtual resource block in the DCI Format 1A; a control channel mode in which the DCI Format 1A is located: a PDCCH and an ePDCCH; an ePDCCH transmission mode in which the DCI Format 1A is located: a diversity transmission mode and a centralized transmission mode; and an ePDCCH cluster in which the DCI Format 1A is located.
    Type: Application
    Filed: August 26, 2013
    Publication date: November 19, 2015
    Inventors: Senbao GUO, Yunfeng SUN, Junfeng ZHANG, Dongli CHEN
  • Patent number: 9130710
    Abstract: The disclosure discloses a method and system for processing control channel information. A receiving side is notified, by a network side via one or more types of the following signaling, of the information required to receive or perform blind detection for a control channel, wherein the signaling part comprises at least: a Radio Resource Control (RRC) signaling, a System Information Block (SIB)x (x=2, 3) signaling, and a Physical Downlink Control Channel (PDCCH) signaling located at the first n (n=1, 2, 3, 4) Orthogonal Frequency-Division Multiplexing (OFDM) symbols. In the control channel information processing technology of the disclosure, the receiving side can be notified, via signaling configuration, of at least the time domain or frequency domain location occupied by the control channel. This scheme allows for full utilization of space division technology, thus reducing the load on a physical downlink control channel, and reducing interference between control channels.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: September 8, 2015
    Assignee: ZTE Corporation
    Inventors: Senbao Guo, Yunfeng Sun, Yuhong Gong, Dongli Chen, Junfeng Zhang
  • Publication number: 20150139105
    Abstract: A method and device for performing interference measurement on interference measurement resources are disclosed, in which a base station side transmits N sets of interference measurement resources on a non-full bandwidth or a full bandwidth, and transmits a location indication signaling of each set of the interference measurement resources to a terminal side; the terminal side determines a location of each set of the interference measurement resources according to the location indication signaling of each set of interference measurement resources, and performs interference measurement on each set of interference measurement resources in accordance with the non-full bandwidth or the full bandwidth; through a technical scheme of the disclosure, the interference measurement can be implemented on different interference measurement resources by employing time domain and frequency domain resource overheads and high layer signaling overheads as less as possible.
    Type: Application
    Filed: July 10, 2013
    Publication date: May 21, 2015
    Inventors: Senbao Guo, Chenchen Zhang, Yunfeng Sun, Dongli Chen
  • Publication number: 20140177547
    Abstract: The disclosure discloses a method and system for processing control channel information. A receiving side is notified, by a network side via one or more types of the following signaling, of the information required to receive or perform blind detection for a control channel, wherein the signaling part comprises at least: a Radio Resource Control (RRC) signaling, a System Information Block (SIB)x (x=2, 3) signaling, and a Physical Downlink Control Channel (PDCCH) signaling located at the first n (n=1, 2, 3, 4) Orthogonal Frequency-Division Multiplexing (OFDM) symbols. In the control channel information processing technology of the disclosure, the receiving side can be notified, via signaling configuration, of at least the time domain or frequency domain location occupied by the control channel. This scheme allows for full utilization of space division technology, thus reducing the load on a physical downlink control channel, and reducing interference between control channels.
    Type: Application
    Filed: March 2, 2012
    Publication date: June 26, 2014
    Applicant: ZTE CORPORATION
    Inventors: Senbao Guo, Yunfeng Sun, Yuhong Gong, Dongli Chen, Junfeng Zhang
  • Patent number: 8675533
    Abstract: The present invention discloses a method for determining a radio frame bearing a multimedia broadcast multicast service notification message, including: a sending end configuring a Multicast Control Channel (MCCH) Modification Period (MCCHMP), a period coefficient (PeriodCoeff) and a notification message offset (NotificationOffset), and when a system frame number (SFN) modulo a ratio of the MCCHMP to the PeriodCoeff is equal to the NotificationOffset, a radio frame corresponding to a value of said SFN is the radio frame of sending the Multimedia Broadcast Multicast Service (MBMS) notification message. The present invention obtains the radio frame of sending the MBMS notification message by less MCCH information, so that the receiving and analyzing processes of the terminal save power.
    Type: Grant
    Filed: November 3, 2010
    Date of Patent: March 18, 2014
    Assignee: ZTE Corporation
    Inventors: Wei Gou, Zijiang Ma, Nan Zhao, Dongli Chen
  • Patent number: 8569282
    Abstract: Chemokine receptor antagonists, in particular, compounds of Formula (I-A) that act as antagonists of the chemokine CCR2 receptor, including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leukocyte accumulation are described herein.
    Type: Grant
    Filed: December 11, 2008
    Date of Patent: October 29, 2013
    Assignee: CytoPathfinder, Inc.
    Inventors: Efrat Ben-Zeev, Dongli Chen, Merav Fichman, Shomir Ghosh, Steffi Koerner, Jian Lin, Yael Marantz, Rosa E. Melendez, Pradyumna Mohanty, Sharon Shacham, Zhaoda Zhang
  • Publication number: 20130070659
    Abstract: The present invention discloses a method for determining a radio frame bearing a multimedia broadcast multicast service notification message, including: a sending end configuring a Multicast Control Channel (MCCH) Modification Period (MCCHMP), a period coefficient (PeriodCoeff) and a notification message offset (NotificationOffset), and when a system frame number (SFN) modulo a ratio of the MCCHMP to the PeriodCoeff is equal to the NotificationOffset, a radio frame corresponding to a value of said SFN is the radio frame of sending the Multimedia Broadcast Multicast Service (MBMS) notification message. The present invention obtains the radio frame of sending the MBMS notification message by less MCCH information, so that the receiving and analyzing processes of the terminal save power.
    Type: Application
    Filed: November 3, 2010
    Publication date: March 21, 2013
    Applicant: ZTE CORPORATION
    Inventors: Wei Gou, Zijiang Ma, Nan Zhao, Dongli Chen
  • Patent number: 8064407
    Abstract: A method and device for realizing smart antenna in WCDMA system are disclosed in the invention, including array antenna, radio frequency channel module, beam forming module, channel environment detection and classification module, beam-forming algorithm selection and weight value generation module. After processing the signals received by the antenna array in RF channel, the baseband array data X including multiple components is obtained, then the channel environment is estimated and identified according to the characteristics of said array data, and the channel type which the channel belongs to is determined; the corresponding adaptive beam forming algorithm is selected according to the identification result of the channel type, so as to calculate the uplink weight value W including multiple components; said array data X and weight value W are multiplied so as to form beam Y.
    Type: Grant
    Filed: December 29, 2005
    Date of Patent: November 22, 2011
    Assignee: ZTE Corporation
    Inventors: Yanwen Wang, Li Zhang, Dongli Chen
  • Publication number: 20110195953
    Abstract: The invention generally relates to thienopyridinone 5-HT4 receptor modulators, and in particular the use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with serotonin action, such as in treating Alzheimer's disease, cognition disorders, depression, and anxiety.
    Type: Application
    Filed: September 30, 2009
    Publication date: August 11, 2011
    Applicant: EPIX Delaware, Inc.
    Inventors: Dale S. Dhanoa, Oren Becker, Silvia Noiman, Pradyumna Mohanty, Dongli Chen, Mercedes Lobera, Laurence Wu, Yael Marantz, Boaz Inbal, Alexander Heifetz, Shay Bar-Haim, Sharon Shacham
  • Patent number: 7982040
    Abstract: The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
    Type: Grant
    Filed: December 24, 2008
    Date of Patent: July 19, 2011
    Assignee: Nanotherapeutics, Inc.
    Inventors: Dale S. Dhanoa, Oren Becker, Silvia Noiman, Pradyumna Mohanty, Dongli Chen, Mercedes Lobera, Laurence Wu, Yael Marantz, Boaz Inbal, Alexander Heifetz, Shay Bar-Haim, Sharon Shacham
  • Publication number: 20110082157
    Abstract: The invention relates to 5-HT receptor antagonists. Novel piperidinylamino-thieno [2,3-d] pyrimidine compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as pulmonary arterial hypertension, migraine, hypertension, disorders of the gastrointestinal tract, restenosis, asthma, obstructive airway disease, prostatic hyperplasia and priapism, anxiety, depression, schizophrenia, neural injury and stroke. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also provided.
    Type: Application
    Filed: June 8, 2010
    Publication date: April 7, 2011
    Inventors: Dale S. Dhanoa, Oren Becker, Silvia Noiman, Sekar A. Reddy, Srinivasa Rao Cheruku, Rosa E. Mele'ndez, Anurag Sharadendu, Dongli Chen, Yael Marantz, Sharon Shacham, Alexander Heifetz, Boaz Inbal, Venkitasamy Kesavan, Shay Bar-Haim
  • Publication number: 20100331298
    Abstract: Chemokine receptor antagonists, in particular, compounds of Formula (I) that act as antagonists of the chemokine CCR2 receptor, including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leukocyte accumulation are described herein.
    Type: Application
    Filed: December 10, 2008
    Publication date: December 30, 2010
    Applicant: CytoPathfinder, Inc.
    Inventors: Efrat Ben-Zeev, Dongli Chen, Merav Fichman, Shomir Ghosh, Steffi Koerner, Jian Lin, Yael Marantz, Rosa E. Melendez, Pradyumna Mohanty, Sharon Shacham, Zhaoda Zhang
  • Publication number: 20100210633
    Abstract: Chemokine receptor antagonists, in particular, compounds of Formula (I) that act as antagonists of the chemokine CCR2 receptor, including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leukocyte accumulation are described herein.
    Type: Application
    Filed: October 12, 2007
    Publication date: August 19, 2010
    Applicant: EPIX Delaware, Inc.
    Inventors: Jian Lin, Dongli Chen, Steffi Koerner, Rosa E. Melendez, Pradyumma Mohanty, Efrat Ben-Zeev, Merav Fichman, Yael Marantz, Oren Becker, Dilara McCauley, Pini Orbach, Ashis K. Saha, Sharon Shacham, Michael Xie
  • Publication number: 20100184749
    Abstract: Chemokine receptor antagonists, in particular, compounds of Formula (I) that act as antagonists of the chemokine CCR2 receptor, including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leukocyte accumulation are described herein.
    Type: Application
    Filed: October 12, 2007
    Publication date: July 22, 2010
    Applicant: EPIX Delaware ,Inc.
    Inventors: Merav Fichman, Rosa E. Melendez, Pradyumna Mohanty, Jian Lin, Dilara McCauley, Boaz Inbal, Mercedes Lobera, Pini Orbach, Ori Kalid, Dongli Chen, Yael Marantz, Michael Xie, Sharon Shacham, Oren Becker
  • Publication number: 20100113485
    Abstract: The invention relates to 5-HT receptor modulators, particularly 5-HT2B antagonists. Novel piperidinylamino-thieno[2,3-d]pyrimidine compounds represented by Formula I, II and III, and uses thereof for treating conditions including pulmonary arterial hypertension, congestive heart failure, and hypertension.
    Type: Application
    Filed: October 30, 2009
    Publication date: May 6, 2010
    Inventors: Dale S. Dhanoa, Oren Becker, Silvia Noiman, Sekar Reddy Alla, Srinivasa Rao Cheruku, Rosa E. Mele'ndez, Anurag Sharadendu, Dongli Chen, Yael Marantz, Sharon Shacham, Alexander Heifetz, Boaz Inbal, Venkitasamy Kesavan, Shay Bar-Haim
  • Patent number: 7612078
    Abstract: The invention relates to 5-HT receptor modulators, particularly 5-HT2B antagonists. Novel piperidinylamino-thieno[2,3-d]pyrimidine compounds represented by Formula I, II and III, and uses thereof for treating conditions including pulmonary arterial hypertension, congestive heart failure, and hypertension.
    Type: Grant
    Filed: March 8, 2005
    Date of Patent: November 3, 2009
    Assignee: Epix Delaware, Inc.
    Inventors: Dale S. Dhanoa, Oren Becker, Silvia Noiman, A. Sekar Reddy, Srinivasa R. Cheruku, Rosa E. Melendez, Anurag Sharadendu, Dongli Chen, Yael Marantz, Sharon Shacham, Alexander Heifetz, Boaz Inbal, Venkitasamy Kesavan, Shay Bar-Haim
  • Patent number: 7598265
    Abstract: The invention generally relates to thienopyridinone 5-HT4 receptor modulators, and in particular the use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with serotonin action, such as in treating Alzheimer's disease, cognition disorders, depression, and anxiety.
    Type: Grant
    Filed: November 10, 2005
    Date of Patent: October 6, 2009
    Assignee: Epix Delaware, Inc.
    Inventors: Dale S. Dhanoa, Oren Becker, Silvia Noiman, Pradyumna Mohanty, Dongli Chen, Mercedes Lobera, Laurence Wu, Yael Marantz, Boaz Inbal, Alexander Heifetz, Shay Bar-Haim, Sharon Shacham